Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
Teva Biotechnologie
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.